Intrinsic Value of S&P & Nasdaq Contact Us

Quipt Home Medical Corp. QIPT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
30/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.70
-53.4%

There have been 25 recent insider transactions recorded for Quipt Home Medical Corp. (QIPT), including 10 buys and 6 sells. Total insider buying was valued at $16.93K and total insider selling at RSU Award.

Notable insiders with recent activity include Roehrig Thomas, Carter Kevin A., Wessel Brian Joseph. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — QIPT

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2025-03-22 Roehrig Thomas Chief Accounting Officer RSU Award 110,000 - - 173,000
2025-03-22 Carter Kevin A. Director RSU Award 174,767 - - 277,892
2025-03-22 Wessel Brian Joseph Director RSU Award 183,135 - - 197,260
2025-03-22 Crawford Gregory John President/ceo RSU Award 936,000 - - 2,770,196
2025-03-22 Mehta Hardik Chief Financial Officer RSU Award 343,347 - - 366,471
2025-03-22 Greenberg Mark Alan Director RSU Award 211,504 - - 528,319
2025-03-22 Bachelder David Exec. VP Operations RSU Award 20,000 - - 22,156
2025-03-22 Gamble Patrick Dennis Exec. VP Operations RSU Award 20,000 - - 60,057
2025-03-22 Miles Mark Alan Chief Compliance Officer RSU Award 110,000 - - 110,000
2025-03-14 Roehrig Thomas Chief Accounting Officer Option Exercise (Sell) 39,375 - - -
2025-03-14 Carter Kevin A. Director Option Exercise (Sell) 53,124 - - -
2025-03-14 Wessel Brian Joseph Director Option Exercise (Sell) 70,625 - - -
2025-03-14 Crawford Gregory John President/ceo Option Exercise (Sell) 118,750 - - -
2025-03-14 Mehta Hardik Chief Financial Officer Option Exercise (Sell) 115,624 - - -
2025-03-14 Greenberg Mark Alan Director Option Exercise (Sell) 115,625 - - -
2024-12-26 Gamble Patrick Dennis Exec VP Operations Informative Buy 7,000 $2.42 $16.93K 30,057
2024-10-01 Carter Kevin A. Director Unknown 53,124 - - -
2024-10-01 Wessel Brian Joseph Director Unknown 70,625 - - -
2024-10-01 Crawford Gregory John President/ceo Unknown 118,750 - - -
2024-10-01 Mehta Hardik Chief Financial Officer Unknown 115,624 - - -
2024-10-01 Greenberg Mark Alan Director Unknown 115,625 - - -
2024-10-01 Bachelder David Exec VP Operations Unknown 50,000 $4.99 $249.5K -
2024-10-01 Gamble Patrick Dennis Exec VP Operations Unknown 15,000 $6.14 $92.1K -
2024-10-01 Miles Mark Alan Chief Compliance Officer Unknown 15,000 $6.14 $92.1K -
2024-10-01 Roehrig Thomas Chief Accounting Officer Unknown 39,375 - - -
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message